See more : Invesco Mortgage Capital Inc. (IVR-PC) Income Statement Analysis – Financial Results
Complete financial analysis of West Pharmaceutical Services, Inc. (WST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of West Pharmaceutical Services, Inc., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
You may be interested
- Eagon Industrial Co., Ltd. (008250.KS) Income Statement Analysis – Financial Results
- Prestige Consumer Healthcare Inc. (PBH) Income Statement Analysis – Financial Results
- Dragon Crown Group Holdings Limited (0935.HK) Income Statement Analysis – Financial Results
- Multibax Public Company Limited (MBAX.BK) Income Statement Analysis – Financial Results
- Greenyard NV (0JZ8.L) Income Statement Analysis – Financial Results
West Pharmaceutical Services, Inc. (WST)
About West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.95B | 2.89B | 2.83B | 2.15B | 1.84B | 1.72B | 1.60B | 1.51B | 1.40B | 1.42B | 1.37B | 1.27B | 1.19B | 1.10B | 1.06B | 1.05B | 1.02B | 913.30M | 699.70M | 541.60M | 490.70M | 419.70M | 396.90M | 430.10M | 469.10M | 449.70M | 452.50M | 458.80M | 412.90M | 365.10M | 348.70M | 338.20M | 329.60M | 323.20M | 308.70M | 288.20M | 253.30M | 235.60M | 190.10M |
| Cost of Revenue | 1.82B | 1.75B | 1.66B | 1.38B | 1.23B | 1.17B | 1.09B | 1.01B | 944.00M | 973.60M | 933.70M | 878.70M | 853.00M | 786.60M | 752.10M | 748.50M | 728.30M | 651.50M | 507.10M | 385.70M | 334.90M | 302.10M | 280.80M | 289.70M | 289.10M | 282.20M | 288.50M | 302.00M | 265.10M | 225.90M | 222.10M | 217.80M | 221.40M | 221.50M | 206.70M | 197.40M | 174.40M | 160.20M | 128.00M |
| Gross Profit | 1.13B | 1.14B | 1.18B | 767.80M | 605.70M | 545.40M | 512.60M | 501.10M | 455.80M | 447.80M | 434.70M | 387.70M | 339.30M | 318.10M | 303.60M | 302.60M | 291.80M | 261.80M | 192.60M | 155.90M | 155.80M | 117.60M | 116.10M | 140.40M | 180.00M | 167.50M | 164.00M | 156.80M | 147.80M | 139.20M | 126.60M | 120.40M | 108.20M | 101.70M | 102.00M | 90.80M | 78.90M | 75.40M | 62.10M |
| Gross Profit Ratio | 38.28% | 39.36% | 41.52% | 35.76% | 32.92% | 31.76% | 32.06% | 33.21% | 32.56% | 31.50% | 31.77% | 30.61% | 28.46% | 28.80% | 28.76% | 28.79% | 28.61% | 28.67% | 27.53% | 28.79% | 31.75% | 28.02% | 29.25% | 32.64% | 38.37% | 37.25% | 36.24% | 34.18% | 35.80% | 38.13% | 36.31% | 35.60% | 32.83% | 31.47% | 33.04% | 31.51% | 31.15% | 32.00% | 32.67% |
| Research & Development | 68.40M | 58.50M | 52.80M | 46.90M | 38.90M | 40.30M | 39.10M | 36.80M | 34.10M | 37.30M | 37.90M | 33.20M | 29.10M | 23.90M | 19.90M | 18.70M | 16.10M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 262.90M | 242.60M | 239.80M | 233.00M | 228.70M | 234.90M | 218.10M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 353.40M | 316.90M | 362.80M | 302.00M | 272.70M | 262.90M | 242.60M | 239.80M | 233.00M | 228.70M | 234.90M | 218.10M | 191.10M | 187.70M | 177.70M | 159.30M | 152.50M | 155.90M | 120.30M | 105.20M | 111.00M | 82.60M | 73.40M | 67.70M | 77.90M | 70.50M | 70.20M | 72.80M | 69.90M | 69.00M | 63.50M | 57.10M | 85.00M | 57.80M | 45.60M | 41.50M | 32.20M | 29.90M | 26.60M |
| Other Expenses | 31.50M | 26.80M | 7.90M | 12.00M | 2.40M | 4.80M | -2.00M | -27.70M | -60.10M | 200.00K | 500.00K | 5.40M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 454.00M | 402.20M | 423.50M | 360.90M | 311.60M | 303.20M | 281.70M | 276.60M | 267.10M | 266.00M | 272.80M | 251.30M | 221.70M | 213.30M | 197.60M | 191.90M | 168.60M | 160.80M | 121.70M | 106.70M | 94.30M | 81.00M | 71.90M | 104.70M | 113.60M | 102.80M | 102.10M | 103.50M | 99.50M | 92.10M | 85.50M | 80.70M | 109.50M | 80.50M | 65.90M | 60.40M | 49.00M | 44.60M | 38.60M |
| Cost & Expenses | 2.27B | 2.15B | 2.08B | 1.74B | 1.55B | 1.48B | 1.37B | 1.28B | 1.21B | 1.24B | 1.21B | 1.13B | 1.07B | 999.90M | 949.70M | 940.40M | 896.90M | 812.30M | 628.80M | 492.40M | 429.20M | 383.10M | 352.70M | 394.40M | 402.70M | 385.00M | 390.60M | 405.50M | 364.60M | 318.00M | 307.60M | 298.50M | 330.90M | 302.00M | 272.60M | 257.80M | 223.40M | 204.80M | 166.60M |
| Interest Income | 28.00M | 5.10M | 1.00M | 1.40M | 3.80M | 2.10M | 1.30M | 1.10M | 1.60M | 3.50M | 1.90M | 1.80M | 1.30M | 600.00K | 800.00K | 1.40M | 6.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 9.00M | 7.90M | 7.20M | 6.80M | 4.70M | 6.30M | 6.50M | 7.00M | 12.50M | 13.00M | 15.10M | 14.90M | 18.20M | 16.80M | 14.40M | 16.00M | 14.50M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 137.30M | 120.60M | 122.30M | 109.10M | 103.40M | 104.40M | 96.70M | 90.70M | 89.90M | 90.00M | 85.20M | 76.90M | 75.70M | 73.20M | 68.10M | 60.60M | 56.60M | 52.70M | 47.40M | 33.20M | 33.00M | 33.00M | 32.00M | 37.00M | 35.70M | 32.30M | 31.90M | 30.70M | 29.60M | 23.10M | 22.00M | 23.60M | 24.50M | 22.70M | 20.30M | 18.90M | 16.80M | 14.70M | 12.00M |
| EBITDA | 844.10M | 887.90M | 895.20M | 531.70M | 399.40M | 355.30M | 335.90M | 319.60M | 220.00M | 273.30M | 249.00M | 200.00M | 183.40M | 161.30M | 166.40M | 186.10M | 157.50M | 149.90M | 122.90M | 94.50M | 84.80M | 82.80M | 74.70M | 75.90M | 102.10M | 97.00M | 93.80M | 84.00M | 77.90M | 70.20M | 63.10M | 63.30M | 23.20M | 43.90M | 56.40M | 49.30M | 46.70M | 45.50M | 35.50M |
| EBITDA Ratio | 28.62% | 29.60% | 31.02% | 24.09% | 21.73% | 14.38% | 14.31% | 13.04% | 9.19% | 12.80% | 11.87% | 11.20% | 10.53% | 10.76% | 9.95% | 10.65% | 20.40% | 18.01% | 19.39% | 15.68% | 17.28% | 18.56% | 19.55% | 21.39% | 21.49% | 28.13% | 20.38% | 22.47% | 18.29% | 19.56% | 17.95% | 18.72% | 6.71% | 14.91% | 16.94% | 16.20% | 19.31% | 18.34% | 16.99% |
| Operating Income | 676.00M | 734.00M | 752.30M | 406.90M | 296.60M | 240.30M | 228.90M | 196.80M | 128.60M | 182.00M | 162.40M | 135.10M | 109.60M | 90.70M | 97.50M | 124.10M | 94.90M | 101.00M | 72.20M | 48.20M | 54.50M | 26.70M | 41.30M | 35.70M | 66.40M | 64.70M | 61.90M | 53.30M | 48.30M | 47.10M | 41.10M | 39.70M | -1.30M | 21.20M | 36.10M | 30.40M | 29.90M | 30.80M | 23.50M |
| Operating Income Ratio | 22.92% | 25.43% | 26.57% | 18.95% | 16.12% | 13.99% | 14.31% | 13.04% | 9.19% | 12.80% | 11.87% | 10.67% | 9.19% | 8.21% | 9.24% | 11.81% | 9.30% | 11.06% | 10.32% | 8.90% | 11.11% | 6.36% | 10.41% | 8.30% | 14.15% | 14.39% | 13.68% | 11.62% | 11.70% | 12.90% | 11.79% | 11.74% | -0.39% | 6.56% | 11.69% | 10.55% | 11.80% | 13.07% | 12.36% |
| Total Other Income/Expenses | 22.00M | -54.10M | -3.40M | -5.60M | -4.80M | 400.00K | -3.40M | -5.40M | -12.50M | -13.00M | -15.30M | -26.50M | -23.20M | -31.50M | -14.40M | -15.10M | -8.50M | -16.50M | -12.00M | -8.20M | -7.50M | -9.50M | -13.40M | -11.10M | -9.30M | -36.80M | -4.20M | -26.10M | -5.70M | -6.40M | -4.30M | -5.70M | -2.50M | -10.50M | -2.20M | -2.90M | -6.70M | -600.00K | 1.90M |
| Income Before Tax | 698.00M | 679.90M | 748.90M | 401.30M | 291.80M | 240.70M | 222.40M | 189.80M | 116.10M | 169.00M | 147.10M | 108.60M | 92.70M | 74.50M | 83.10M | 109.50M | 86.40M | 84.50M | 45.20M | 41.20M | 47.00M | 17.20M | 27.80M | 3.10M | 57.10M | 27.90M | 57.70M | 27.20M | 42.60M | 40.70M | 36.80M | 34.00M | -3.80M | 10.70M | 33.90M | 27.50M | 23.20M | 30.20M | 25.40M |
| Income Before Tax Ratio | 23.66% | 23.55% | 26.45% | 18.69% | 15.86% | 14.02% | 13.91% | 12.58% | 8.29% | 11.89% | 10.75% | 8.58% | 7.77% | 6.74% | 7.87% | 10.42% | 8.47% | 9.25% | 6.46% | 7.61% | 9.58% | 4.10% | 7.00% | 0.72% | 12.17% | 6.20% | 12.75% | 5.93% | 10.32% | 11.15% | 10.55% | 10.05% | -1.15% | 3.31% | 10.98% | 9.54% | 9.16% | 12.82% | 13.36% |
| Income Tax Expense | 122.30M | 114.70M | 107.20M | 72.50M | 59.00M | 41.40M | 80.90M | 54.40M | 26.30M | 47.20M | 40.20M | 32.70M | 23.50M | 13.60M | 13.50M | 23.70M | 17.20M | 24.60M | -400.00K | 11.10M | 16.70M | 4.10M | 8.60M | 1.50M | 18.40M | 21.20M | 13.30M | 10.80M | 13.90M | 13.40M | 14.30M | 14.30M | 4.70M | 6.40M | 13.20M | 10.10M | 9.50M | 13.20M | 10.40M |
| Net Income | 593.40M | 585.90M | 661.80M | 346.20M | 241.70M | 206.90M | 150.70M | 143.60M | 95.60M | 127.10M | 112.30M | 80.70M | 75.50M | 65.30M | 72.60M | 86.00M | 70.70M | 67.10M | 45.60M | 19.40M | 31.90M | 18.40M | -5.20M | 1.60M | 38.70M | 6.70M | 44.40M | 16.40M | 28.70M | 27.30M | 23.50M | 19.70M | -8.50M | 4.30M | 20.70M | 17.40M | 13.70M | 17.00M | 15.00M |
| Net Income Ratio | 20.12% | 20.30% | 23.37% | 16.13% | 13.14% | 12.05% | 9.42% | 9.52% | 6.83% | 8.94% | 8.21% | 6.37% | 6.33% | 5.91% | 6.88% | 8.18% | 6.93% | 7.35% | 6.52% | 3.58% | 6.50% | 4.38% | -1.31% | 0.37% | 8.25% | 1.49% | 9.81% | 3.57% | 6.95% | 7.48% | 6.74% | 5.82% | -2.58% | 1.33% | 6.71% | 6.04% | 5.41% | 7.22% | 7.89% |
| EPS | 7.99 | 7.88 | 8.90 | 4.68 | 3.27 | 2.80 | 2.04 | 1.96 | 1.33 | 1.79 | 1.61 | 1.19 | 1.12 | 0.98 | 1.11 | 1.33 | 1.08 | 1.05 | 0.75 | 0.57 | 0.75 | 0.33 | -0.09 | 0.03 | 0.65 | 0.10 | 0.67 | 0.25 | 0.43 | 0.43 | 0.37 | 0.32 | -0.14 | 0.07 | 0.32 | 0.27 | 0.21 | 0.27 | 0.24 |
| EPS Diluted | 7.88 | 7.73 | 8.67 | 4.57 | 3.21 | 2.74 | 1.99 | 1.91 | 1.30 | 1.75 | 1.57 | 1.15 | 1.08 | 0.95 | 1.06 | 1.25 | 1.02 | 1.00 | 0.71 | 0.56 | 0.75 | 0.33 | -0.09 | 0.03 | 0.64 | 0.10 | 0.67 | 0.25 | 0.43 | 0.43 | 0.37 | 0.31 | -0.14 | 0.07 | 0.32 | 0.27 | 0.21 | 0.27 | 0.24 |
| Weighted Avg Shares Out | 74.30M | 74.40M | 74.40M | 73.90M | 74.00M | 73.90M | 73.90M | 73.30M | 72.00M | 70.90M | 69.60M | 68.00M | 67.40M | 66.60M | 65.60M | 64.80M | 65.40M | 64.40M | 62.20M | 60.00M | 58.00M | 57.80M | 57.34M | 57.63M | 59.66M | 65.74M | 65.90M | 65.67M | 66.23M | 64.22M | 63.51M | 62.54M | 61.82M | 63.70M | 64.69M | 65.05M | 64.47M | 64.15M | 63.16M |
| Weighted Avg Shares Out (Dil) | 75.30M | 75.80M | 76.30M | 75.80M | 75.40M | 75.40M | 75.80M | 75.00M | 73.80M | 72.80M | 71.40M | 71.80M | 74.00M | 73.40M | 72.60M | 72.20M | 72.40M | 67.20M | 65.00M | 61.60M | 58.20M | 57.80M | 57.39M | 57.64M | 60.19M | 66.02M | 66.29M | 65.67M | 66.23M | 64.22M | 63.95M | 63.04M | 61.82M | 63.70M | 65.20M | 65.05M | 64.47M | 64.15M | 63.16M |
West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa.
Will West Pharmaceutical (WST) Beat Estimates Again in Its Next Earnings Report?
West Pharmaceutical (WST) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Is a Beat Likely for West Pharmaceutical (WST) in Q1 Earnings?
West Pharmaceutical's (WST) first-quarter 2024 results are likely to reflect strength in its Proprietary Products business. However, unfavorable currency movements might have hurt the top and bottom lines.
Ex-Dividend Reminder: Lennar, Lowe's And West Pharmaceutical
On 4/23/24, Lennar, Lowe's Companies and West Pharmaceutical Services, will all trade ex-dividend for their respective upcoming dividends. Lennar will pay its quarterly dividend of $0.50 on 5/8/24, Lowe's Companies will pay its quarterly dividend of $1.10 on 5/8/24, and...
West Pharmaceutical Services (WST) Expected to Beat Earnings Estimates: Should You Buy?
West Pharmaceutical (WST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Reasons to Hold West Pharmaceutical (WST) in Your Portfolio Now
West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.
West to Host First-Quarter 2024 Conference Call
EXTON, Pa. , April 11, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter financial results before the market opens on Thursday, April 25,...
3 Pharma Stocks to Sell in March Before They Crash & Burn
Recent trends in the stock market have seen a shift in investor interest from tech giants, known as the Magnificent 7, towards pharmaceutical companies, particularly those involved in weight-loss drugs. But, it's important to identify which pharma stocks to sell...
Reasons to Hold West Pharmaceutical (WST) in Your Portfolio Now
West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.
Strength Seen in West Pharmaceutical (WST): Can Its 5.7% Jump Turn into More Strength?
West Pharmaceutical (WST) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Source: https://incomestatements.info
Category: Stock Reports
What were West Pharmaceutical’s net sales in Q3 2024?
(NYSE: WST) today announced its financial results for the third-quarter 2024 and declared a fourth-quarter 2024 dividend. Net sales of $746.9 million declined 0.1%; organic net sales decline was 0.5%. Reported-diluted EPS of $1.85, compared to $2.14 in the same period last year.